Hyperbilirubinemia Management from 27 - 40+ weeks

Clinical decision support for neonatal hyperbilirubinemia based on the AAP 2022 and Stanford Premie BiliRecs guidelines.

The guideline is chosen from gestational age at birth and age:

  • Born at 35 or more weeks: AAP 2022
  • Born before 35 weeks, now 27 0/7 to 35 0/7 weeks postmenstrual age: Stanford Premie BiliRecs (not intended for infants < 48 hours of age)
  • Out of range: Born before 35 weeks, now beyond 35 0/7 weeks postmenstrual age: recommendations from both for comparison (Stanford Premie BiliRecs at 35 0/7 weeks PMA, and AAP 2022 as if born at 35 completed weeks)

Age and Bilirubin

Neurotoxicity risks
(required for AAP 2022)
Plot scale (AAP 2022)
Gap analysis (born < 35, PMA > 35)
Reset form


Optional age calculator



Script by Joseph Chou

DISCLAIMER

The User acknowledges and agrees that this tool will be used only as a reference aid, and that the information contained in the product is not intended to be (nor should it be used as) a substitute for the exercise of professional judgement.

In view of the possibility of human error or changes in medical science, the User should confirm the information in the product through independent sources. This product is provided without warranties of any kind, express or implied, and the author disclaims any liability, loss, or damage caused by it or its content.

By continuing to use this product, you have indicated your acceptance of these terms.


Neurotoxicity Risk Factors: AAP 2022

  • albumin < 3 g/dL
  • isoimmune hemolytic disease
  • G6PD deficiency
  • other hemolytic conditions
  • sepsis
  • clinical instability in previous 24 hours
  • (prematurity accounted for by distinct threshold curves)

Neurotoxicity Risk Factors: Stanford Premie BiliRecs

  • serum albumin levels < 2.5 g/dL
  • rapidly rising TSB levels suggesting hemolytic disease
  • clinically unstable, if they have one or more of the following conditions:
    • blood pH < 7.15
    • blood culture positive sepsis in the prior 24 hours
    • apnea and bradycardia requiring cardiorespiratory resuscitation (bagging or intubation) during the previous 24 hours
    • hypotension requiring vasopressor treatment during the previous 24 hours
    • mechanical ventilation at the time of blood sampling

Based on

PediTools
© 2012 – 2026 Joseph Chou